Lanreotide in patients with lung neuroendocrine tumors: The randomized double-blind placebo-controlled international phase 3 SPINET study Meeting Abstract


Authors: Reidy-Lagunes, D.; Kulke, M.; Wolin, E.; Singh, S.; Ferone, D.; Hoersch, D.; Mirakhur, B.; Hoffmanns, P.; Houchard, A.; Caplin, M.; Baudin, E.
Abstract Title: Lanreotide in patients with lung neuroendocrine tumors: The randomized double-blind placebo-controlled international phase 3 SPINET study
Meeting Title: IASLC 17th World Conference on Lung Cancer
Keywords: progression-free survival; lanreotide; lung neuroendocrine tumors
Journal Title: Journal of Thoracic Oncology
Volume: 12
Issue: 1 Suppl.
Meeting Dates: 2016 Dec 4-7
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2017-01-01
Start Page: S1516
End Page: S1517
Language: English
ACCESSION: WOS:000413055803429
PROVIDER: wos
DOI: 10.1016/j.jtho.2016.11.2090
Notes: Meeting Abstract: PUB0119 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Diane Lauren Reidy
    294 Reidy